Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT

Blood

Volumn 99, Issue 1, 2002, Pages 199-206

  Bochkov, Valery N ^b   Mechtcheriakova, Diana ^b   Lucerna, Marcus ^b   Huber, Joakim ^b   Malli, Roland ^b   Graier, Wolfgang F ^b   Hofer, Erhard ^b   Binder, Bernd R ^b   Leitinger, Norbert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM; CYCLOSPORIN A; EARLY GROWTH RESPONSE FACTOR 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHOLIPASE A2; PHOSPHOLIPID; PROTEIN KINASE C INHIBITOR; REPRESSOR PROTEIN; THROMBOPLASTIN; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CALCIUM CELL LEVEL; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID OXIDATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036096132     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.1.199     Document Type: Article

References (45)

1. Cell biology of tissue factor, the principal initiator of blood coagulation
2. Initiation of coagulation by tissue factor
3. Tissue factor in health and disease
4. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
5. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X
6. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells
7. MM-LDL atherogenesis - A major role for phospholipid oxidation products
8. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
9. Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein
10. Proinflammatory cytokines
11. Oxidized LDL modulates activation of NFkappaB in mononuclear phagocytes by altering the degradation of IkappaBs
12. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils
13. Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors
14. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1
15. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: A role for tissue factor gene expression
16. Specificity, diversity and convergence in VEGF and TNFalpha signaling events leading to tissue factor upregulation via EGR-1 in endothelial cells
17. Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1
18. Submaximal stimulation of porcine endothelial cells causes focal Ca2+ elevation beneath the cell membrane
19. Subplasmalemmal ryanodine-sensitive Ca2+ release contributes to Ca2+-dependent K+ channel activation in a human umbilical vein endothelial cell line
20. Intracellular concentrations of fura-2 and fura-2/am in vascular smooth muscle cells following perfusion loading of fura-2/am in arterial segments
21. Nucleocytoplasmic shuttling factors including Ran and CRM1 mediate nuclear export of NFAT In vitro
22. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B
23. Multiple signals converging on NF-kappaB
24. Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress
25. Regulation of the tissue factor gene
26. Regulation of the tissue factor gene
27. Pathways of Egr-1-mediated gene transcription in vascular biology
28. NAB2: A transcriptional brake for activated gene expression in the vessel wall?
29. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades
30. Transcription factors of the NFAT family: Regulation and function
31. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A [see comments]
32. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex
33. Histamine induces nuclear factor of activated T cell-mediated transcription and cyclosporin A-sensitive interleukin-8 mRNA expression in human umbilical vein endothelial cells
34. Gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells
35. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells
36. Role of endocytosis in the transactivation of nuclear factor-kappaB by oxidized low-density lipoprotein
37. Oxidized low density lipoprotein suppresses activation of NF kappa B in macrophages via a pertussis toxin-sensitive signaling mechanism
38. Oxidized low density lipoprotein inhibits lipopoly-saccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages
39. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis [see comments]
40. Up-regulation of vascular endothelial growth factor receptor Fit-1 after endothelial denudation: Role of transcription factor Egr-1
41. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages
42. Activation of mitogen-activated protein kinase by oxidized low-density lipoprotein in canine cultured vascular smooth muscle cells
43. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation
44. Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine
45. Determinants of bioactivity of oxidized phos-pholipids: Specific oxidized fatty acyl groups at the sn-2 position